|Minimum Order Quantity||1 Bottle|
|Strength/Dose (in mg or ml)||100 mg + 400 mg|
|Pack Size||28 Tablets|
|Product Type||Finish Product|
The VELPANAT (Velpatasvir and Sofosbuvir) is the generic version of US Company Gilead Sciences new drug is called Epclusa. Generic Epclusa is the first developed Hepatitis C medication that was approved by FDA for all genotypes of Hepatitis C. EPCLUSA was also found to be highly effective in patients with GT1, GT4, GT5 and GT6, with overall cure rates ranging from 97–100%. Epclusa is also the first single tablet regimen approved for the treatment of patients with HCV genotype 2 and 3, without the need for Ribavirin.
Velpanat Velpatasvir 100 mg and Sofosbuvir 400mg tablet is used in the treatment of chronic hepatitis C .
How it works :
Velpanat (Velpatasvir and Sofosbuvir) tablet is an antiviral drug that belongs to a class of medicines called nucleotide polymerase inhibitors. It inhibits an enzyme RNA polymerase which is essential for viral replication and thus decreases the amount of Hepatitis C virus in the body thereby resulting in less liver damage and improved liver function.
- Item Code: Velpanat Tablet
- Port of Dispatch: Mumbai
- Delivery Time: 7 Days